Emtricitabine

CAS 143491-57-0 11 current records 3 historicalSmall Molecule

Who holds supplier records for Emtricitabine? 11 organisations hold a current record for Emtricitabine: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (8) and China (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Emtricitabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/emtricitabine

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Emtricitabine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8China2Country not recorded for 1
  • MATRIX PHARMACORP PRIVATE LTD
    Active DMF 27455, 19566, 31457 · latest filing Mar 2017
    India
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 20708, 43664 · latest filing Mar 2026
    India Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 33068, 21612 · latest filing Oct 2018
    India Company GMP cert on record
  • Arene Life Sciences Limited
    Active DMF 34105 · latest filing Oct 2019
    India
  • Cipla Limited
    Active DMF 19785 · latest filing Sept 2006
    India Company GMP cert on record
  • Laurus Labs Limited
    Active DMF 23773 · latest filing Apr 2010
    India Company GMP cert on record
  • Lupin Limited
    Active DMF 22944 · latest filing Sept 2009
    India Company GMP cert on record
  • Macleods Pharmaceuticals Ltd.
    Active DMF 25001 · latest filing May 2011
    India Company GMP cert on record
  • Shanghai Desano Chemical Pharmaceutical Co., Ltd
    Active DMF 25617 · latest filing Dec 2011
    China
  • Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.
    Active DMF 24975, 42557 · latest filing Oct 2025
    China
  • VIVIN DRUGS AND PHARMACEUTICALS LTD
    Active DMF 32096 · latest filing Nov 2017
Need Emtricitabine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Emtricitabine are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Overview

Emtricitabine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL885).

Chemical identity

IUPAC name
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
Canonical SMILES
C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F
InChIKey
XQSPYNMVSIKCOC-NTSWFWBYSA-N
Synonyms
524-W-91, 524W91, BW-524W91, Coviracil, Emtricitabina, (-)-emtricitabine, Emtricitabine, Emtricitabine, (-)-, Emtricitabine component of atripla, Emtricitabine component of biktarvy, Emtricitabine component of complera, Emtricitabine component of descovy

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Mechanism of action
Nucleoside Reverse Transcriptase Inhibitors
Chemical structure
Nucleosides

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Emtricitabine?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Emtricitabine: MATRIX PHARMACORP PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), Arene Life Sciences Limited (India), Cipla Limited (India), Laurus Labs Limited (India), Lupin Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Emtricitabine Drug Master Files are active?

MATRIX PHARMACORP PRIVATE LTD (DMF 27455, 19566), APITORIA PHARMA PRIVATE LTD (DMF 20708, 43664), Hetero Labs Limited (DMF 33068, 21612), Arene Life Sciences Limited (DMF 34105), Cipla Limited (DMF 19785), Laurus Labs Limited (DMF 23773), Lupin Limited (DMF 22944) and Macleods Pharmaceuticals Ltd. (DMF 25001) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Emtricitabine records mean?

3 organisations have only inactive Type II DMFs for Emtricitabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Emtricitabine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Emtricitabine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.